Secondary Antibodies

Immunogen cysteine and glycine-rich protein 2 recombinant protein epitope signature tag (PrEST) Application Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.

Immunogen cystatin SA Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The

Immunogen Synthetic peptide directed towards the C terminal region of human CSTF2T Biochem/physiol Actions CSTF2T may play a significant role in AAUAAA-independent mRNA polyadenylation in germ cells. It is directly involved in the binding to

Immunogen Synthetic peptide directed towards the C terminal region of human CSTF2T Biochem/physiol Actions CSTF2T may play a significant role in AAUAAA-independent mRNA polyadenylation in germ cells. It is directly involved in the binding to

Immunogen cleavage stimulation factor, 3&#8242 pre-RNA, subunit 2, 64kDa, tau variant Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are

Immunogen cancer/testis antigen 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

C-terminal-binding protein 2 (UniProt P56545 also known as CtBP2) is a nuclear protein encoded by the CTBP2 gene (Gene ID 1488) in human. CtBP1 and CtBP2 are closely related proteins that are encoded by the vertebrate genome and perform both

The gene CTBP2 (C-terminal binding protein 2) encodes a member of the CtBP-family. The gene is mapped to human chromosome 21q21.

The gene CTBP2 (C-terminal binding protein 2) encodes a member of the CtBP-family. The gene is mapped to human chromosome 21q21.

Immunogen C-terminal binding protein 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas

Immunogen CDNA FLJ26957 fis, clone SLV00486 {ECO:0000313|EMBL:BAC85360.1} Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000424007} Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human